Allarity Therapeutics, Inc. Share Price

Allarity Therapeutics, Inc. Share Price

NASDAQ: ALLR | Micro Cap
$0.96
+$0.03 (3.11%) Last updated on 29 Oct, 2026 | 00:32 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Allarity Therapeutics, Inc. Stock Performance

Open
$0.94
Prev. Close
$0.93
Circuit Range
N/A
Day Range
$0.94 - $0.96
Year Range
$0.78 - $1.82
Volume
835
Average Traded
$0.96

Allarity Therapeutics, Inc. Share Price Today

As of 29 October 2026, Allarity Therapeutics, Inc.'s share price is $0.96. The stock opened at $0.94, compared to its previous close of $0.93. During today's trading session, Allarity Therapeutics, Inc.'s share price traded between $0.94 and $0.96, with an average price of $0.95. Over the past 52 weeks, the stock has recorded a high of $1.82 and a low of $0.78. In terms of performance, Allarity Therapeutics, Inc.'s share price has declined by 29.49% over the last six months and is down 33.87% on a year-on-year basis.

Allarity Therapeutics, Inc. Share Price Chart

Line chart of the Allarity Therapeutics, Inc. price trend over the selected period. The price rose overall, ranging from 0.92 to 0.96, ending at 0.96.
$0.94$0.96
L
Show Current Price
H

Allarity Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$13.79M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.78
Revenue (TTM)
$320.00M
Return On Equity (TTM)
-348.81%
Profit Margin
-3509.38%
Debt to Equity
6.30
Quarterly Earnings Growth YoY
-21.35%

Allarity Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.32$0.03$0.00
Net Profit-$2.81-$3.37-$2.75-$3.41
Net Profit MarginN/A-1053.13%-9166.67%N/A
Income ChangeN/A-19.93%18.40%-24.00%

Allarity Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.32
Net Profit-$21.05-$20.42-$25.15-$11.23
Net Profit MarginN/AN/AN/A-3509.38%
Income ChangeN/A2.99%-23.16%55.35%

About Allarity Therapeutics, Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States. It is focused on the clinical development of its lead program: Stenoparib, which is being co-developed with a drug specific DRP companion diagnostic.

Allarity Therapeutics, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$1.03
$0.96
-8.76%
Sep 2026
$1.41
$1.05
-23.91%
Aug 2026
$1.24
$1.38
+12.20%
Jul 2026
$1.28
$1.23
-4.65%
Jun 2026
$1.56
$1.29
-22.29%
May 2026
$1.32
$1.66
+22.06%
Apr 2026
$1.12
$1.36
+24.77%
Mar 2026
$0.98
$1.09
+10.21%
Feb 2026
$0.94
$0.99
-3.04%
Jan 2026
$1.10
$1.02
-1.92%
Dec 2025
$1.29
$1.04
-20.61%
Nov 2025
$1.40
$1.31
-9.66%

ALLR Share Price FAQs